Production (Stage)
CervoMed Inc.
CRVO
$7.26
$0.141.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -11.31% | 11.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.31% | 11.45% | |||
| Cost of Revenue | -31.73% | 38.27% | |||
| Gross Profit | 40.70% | -54.60% | |||
| SG&A Expenses | 2.87% | 4.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -23.21% | 28.17% | |||
| Operating Income | 26.76% | -34.18% | |||
| Income Before Tax | 27.02% | -41.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 27.02% | -41.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 27.02% | -41.07% | |||
| EBIT | 26.76% | -34.18% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 26.97% | -40.99% | |||
| Normalized Basic EPS | 26.97% | -40.98% | |||
| EPS Diluted | 26.97% | -40.02% | |||
| Normalized Diluted EPS | 26.97% | -40.98% | |||
| Average Basic Shares Outstanding | -0.05% | 0.05% | |||
| Average Diluted Shares Outstanding | -0.05% | 0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||